Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Kojic acid

🥰Excellent
Catalog No. T5889Cas No. 501-30-4

Kojic acid is a fungal metabolite that inhibits tyrosinase, an enzyme involved in melanin synthesis, with an IC50 value of 30.6 μM for mushroom tyrosinase.

Kojic acid

Kojic acid

🥰Excellent
Purity: 99.34%
Catalog No. T5889Cas No. 501-30-4
Kojic acid is a fungal metabolite that inhibits tyrosinase, an enzyme involved in melanin synthesis, with an IC50 value of 30.6 μM for mushroom tyrosinase.
Pack SizePriceAvailabilityQuantity
5 g$39In Stock
10 g$55In Stock
1 mL x 10 mM (in DMSO)$43In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Kojic acid"

Select Batch
Purity:99.34%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Kojic acid is a fungal metabolite that inhibits tyrosinase, an enzyme involved in melanin synthesis, with an IC50 value of 30.6 μM for mushroom tyrosinase.
In vitro
Kojic acid(KA) (50 μg/mL) was found to decrease the growth by 62% (IC50 34 μg/mL) and 79% (IC50 27.84 μg/mL) of promastigotes and amastigotes in vitro, respectively. KA-treated amastigotes showed the presence of vesicles bodies into the flagellar pocket, and an intense intracellular vacuolization and swelling of the mitochondrion. During the in vitro interaction of parasites and the host cell, KA reverses the superoxide anions (O2-) inhibitory mechanism promoted by parasite[1].
In vivo
4 weeks after KA-topical formulation treatment of infected animals, a healing process was observed with a high production of collagen fibers and a decrease in parasite burden. The great potential of KA as an anti-leishmanial compound[1].
Cell Research
Amazonensis promastigotes (10^6 parasites/mL) were inoculated in a 24-well plate containing RPMI medium supplemented with 10% inactivated fetal bovine serum treated with different concentrations of KA and incubated at 25 °C for 5 days without medium replacement. Every 24 h after treatment, aliquots were harvested and the effect of Kojic acid on promastigotes growth was evaluated using a Neubauer chamber and compared with untreated parasites culture. The cultures were performed in triplicate[1].
Animal Research
Animals (eight-week-old female Golden hamsters) were infected with 10^6 of L. amazonensis promastigotes/mL during the stationary growth phase with a maximum volume of 0.2 mL on both hind paws.?Animals were separated in 3 groups: untreated (n?=?5);?KA-treated 100 mg/kg/day (n?=?5) and KA vehicle (n?=?5).?KA topical formulation treatment was initiated after 5 weeks of infection.?The KA formulation and vehicle was applied topically to all lesions once daily for 4 weeks.?Control groups were also maintained in parallel.?During the treatment period, the lesion size was measured weekly using a caliper.?Width and height of both hind paws were used to calculate the lesion area (mm^2)[1].
Chemical Properties
Molecular Weight142.11
FormulaC6H6O4
Cas No.501-30-4
SmilesOCC1=CC(=O)C(O)=CO1
Relative Density.1.1712 g/cm3 (Estimated)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 55 mg/mL (387.02 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM7.0368 mL35.1840 mL70.3680 mL351.8401 mL
5 mM1.4074 mL7.0368 mL14.0736 mL70.3680 mL
10 mM0.7037 mL3.5184 mL7.0368 mL35.1840 mL
20 mM0.3518 mL1.7592 mL3.5184 mL17.5920 mL
50 mM0.1407 mL0.7037 mL1.4074 mL7.0368 mL
100 mM0.0704 mL0.3518 mL0.7037 mL3.5184 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Kojic acid | purchase Kojic acid | Kojic acid cost | order Kojic acid | Kojic acid chemical structure | Kojic acid in vivo | Kojic acid in vitro | Kojic acid formula | Kojic acid molecular weight